Valeant Senior Official Leaves Amid Allergan Takeover Battle - Presented by: The Aol. On Network

An executive vice-president of Valeant Pharmaceuticals International Inc will leave the company, even as the Canadian drugmaker fends off criticism about management turnover from its takeover target Allergan Inc . Valeant confirmed late on Friday after inquiries by Reuters, Executive vice-president and company group chairman Ryan Weldon will leave. Like Chief Executive Mike Pearson, Weldon previously worked for management consulting firm McKinsey & Co.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
BAC $ 15.15 0.28 ▼ 1.81%
PBR $ 6.01 0.39 ▼ 6.09%
AAPL $ 117.16 1.74 ▼ 1.46%
MSFT $ 40.40 1.61 ▼ 3.83%
TVIX $ 3.54 0.55 ▲ 18.39%
T $ 32.92 0.04 ▼ 0.12%
GE $ 23.89 0.19 ▼ 0.79%
SIRI $ 3.55 0.04 ▼ 1.11%

As of 1/30/2015, 04:15 PM
More Most Active